Home / Recalls / Lannett Company Inc. / D-0096-2026

D-0096-2026 Class II Ongoing

Recalled by Lannett Company Inc. — Seymour, IN

Recall Details

Product Type
Drugs
Report Date
October 29, 2025
Initiation Date
October 10, 2025
Termination Date
N/A
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
46,848 90-count bottles

Product Description

Niacin Extended-release Tablets, USP, 1,000 mg, Rx Only, 90 Tablets per bottle, Distributed by: Lannett Company, Inc., Philadelphia, PA 19136. NDC: 62175-322-46

Reason for Recall

Failed Dissolution Specifications

Distribution Pattern

Nationwide in the USA

Code Information

Lot, expiry: 21264027A, Exp 10/30/2025; 22266446A, Exp 12/31/2025; 22266901A, Exp 02/28/2026; 22267553A, 22267554A, Exp 03/31/2026; 22267555A, Exp 02/28/2026; 22267992A, Exp 04/30/2026; 22267993A, 22267994A, Exp 05/31/2026

Other recalls by Lannett Company Inc.

  • D-0642-2025 Class II — Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate a (August 19, 2025)
  • D-0599-2025 Class II — Lisdexamfetamine Dimesylate Capsules, 40 mg, 100-count bottles, Rx Only, Distrib (August 11, 2025)
  • D-0112-2025 Class II — Lisdexamfetamine Dimesylate Capsules, 10 mg, 100 Capsules per bottle, Rx only, D (October 25, 2024)
  • D-0161-2023 Class III — Triamterene and Hydrochlorothiazide Capsules, USP (37.5 mg/25 mg), Rx Only, [100 (November 9, 2022)
  • D-0160-2023 Class III — Triamterene and Hydrochlorothiazide Capsules, USP (37.5 mg/25 mg), Rx Only, 1000 (November 9, 2022)
  • D-0558-2022 Class II — Diazepam Oral Solution (Concentrate), 25 mg per 5 mL (5 mg/mL), 30 mL BOTTLE and (February 9, 2022)
  • D-1508-2020 Class II — Prednisone Tablets, USP 2.5 mg, 100 tablets, Rx only, Distributed by: Lannett C (August 10, 2020)
  • D-0630-2020 Class I — Levetiracetam Oral Solution 100mg/mL, 473 mL (16 fl. oz.) Bottles, Rx Only, Dist (December 6, 2019)
  • D-0309-2020 Class II — Lannett Ranitidine Syrup (Ranitidine Oral Solution, USP), 15mg/mL Rx Only Distr (October 28, 2019)
  • D-0996-2019 Class III — Oxybutynin Chloride, Extended-Release Tablets USP, 10 mg, 100 Tablet, Rx Only, D (February 21, 2019)